Manoel O Moraes Selected Research

neosergeolide

8/2012

Involvement of intrinsic mitochondrial pathway in neosergeolide-induced apoptosis of human HL-60 leukemia cells: the role of mitochondrial permeability transition pore and DNA damage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manoel O Moraes Research Topics

Disease

20	Neoplasms (Cancer) 10/2013 - 05/2005
8	Leukemia 10/2013 - 04/2006
4	Chromosome Aberrations (Chromosome Abnormalities) 09/2011 - 06/2009
3	Necrosis 01/2012 - 10/2009
3	Sarcoma 180 09/2011 - 06/2010
2	Glioblastoma (Glioblastoma Multiforme) 09/2011 - 08/2011
1	Fever (Fevers) 08/2016
1	Kidney Diseases (Kidney Disease) 08/2016
1	Diarrhea 08/2016
1	Body Weight (Weight, Body) 01/2013
1	End Stage Liver Disease 01/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012
1	Schizophrenia (Dementia Praecox) 01/2012
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2011
1	Ulcer 12/2010
1	Hemolysis 09/2010
1	Sarcoma (Soft Tissue Sarcoma) 08/2010
1	Malaria 02/2009
1	Dengue (Dengue Fever) 02/2009
1	Colonic Neoplasms (Colon Cancer) 05/2005

Drug/Important Bio-Agent (IBA)

3	Volatile Oils (Essential Oils)IBA 04/2013 - 12/2011
3	Ethidium (Ethidium Bromide)IBA 01/2012 - 10/2009
3	Acridine OrangeIBA 01/2012 - 10/2009
3	AntioxidantsIBA 01/2012 - 05/2005
3	DNA (Deoxyribonucleic Acid)IBA 09/2011 - 04/2006
2	LatexIBA 09/2011 - 08/2010
2	AlkaloidsIBA 09/2011 - 04/2007
2	Biological ProductsIBA 12/2010 - 09/2009
2	biflorinIBA 10/2010 - 05/2005
2	ProceraIBA 08/2010 - 06/2010
1	Analgesics (Analgesic Drugs)IBA 08/2016
1	(4- methoxyphenyl)(3,4,5- trimethoxyphenyl)methanoneIBA 10/2013
1	TubulinIBA 10/2013
1	Canavalia lectinIBA 10/2012
1	LectinsIBA 10/2012
1	Mitochondrial Permeability Transition PoreIBA 08/2012
1	neosergeolideIBA 08/2012
1	Ketamine FDA LinkGeneric 01/2012
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2012
1	mangiferinIBA 01/2012
1	beta-lapachoneIBA 09/2011
1	SteroidsIBA 09/2011
1	PhenolsIBA 09/2011
1	pisosterolIBA 08/2011
1	Agrochemicals (Agricultural Chemicals)IBA 07/2011
1	PesticidesIBA 07/2011
1	Complex MixturesIBA 07/2011
1	hardwickic acidIBA 12/2010
1	Effector CaspasesIBA 12/2010
1	Bromodeoxyuridine (BrdU)IBA 12/2010
1	Clerodane DiterpenesIBA 12/2010
1	PhosphatidylserinesIBA 12/2010
1	1- (acetyloxy)- 3,5,6,6a,7,8,9,10- octahydro- 10- hydroxy- 7,8- dimethyl- 7- (3- methylpenta- 2,4- dien- 1- yl)naphtho(1,8a- c)furan- 3,5- diyl dibutanoateIBA 12/2010
1	Trypan Blue FDA Link 12/2010
1	BufanolidesIBA 09/2010
1	IodoacetamideIBA 08/2010
1	Proteins (Proteins, Gene)FDA Link 08/2010
1	Methylene Chloride (Dichloromethane)IBA 06/2010
1	Antimitotic AgentsIBA 06/2010
1	HexanesIBA 06/2010
1	AcetoneIBA 06/2010
1	ethyl acetateIBA 06/2010
1	Methanol (Carbinol)IBA 06/2010
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 10/2009
1	xylopic acidIBA 10/2009
1	DiterpenesIBA 10/2009
1	AcidsIBA 10/2009
1	piperlongumineIBA 06/2009
1	Antimalarials (Antimalarial Agents)IBA 02/2009
1	PolyketidesIBA 03/2008
1	PterocarpansIBA 04/2006
1	thiocyanateIBA 05/2005

Therapy/Procedure

2	Therapeutics 01/2012 - 08/2011
1	Liver Transplantation 01/2013
1	Aftercare (After-Treatment) 08/2011